Boston Scientific Launches Drug Eluting Stent Solution to Treat Severe Lesions ... Stockhouse Boston Scientific has launched in European countries the PROMUS ELEMENT™ PLUS BTK (Below The Knee) Everolimus-Eluting Stent System for the treatment of certain severe peripheral artery lesions. The Drug Eluting Stent (DES) has CE Mark approval ... |
